
    
      Patients will be recruited among patient refered to our department for a breast cancer and
      needing an axillary dissection. Enrolled patients will have an injection of Lanreotide or
      placebo the day before surgery when they arrive in their room. The quantity of lymph in
      axillary drain will by daily noted until day 4. The patient will be evaluated at D15, D30 and
      M6 for pain, lymphocele and adverse events.

      Data will be compared in the 2 groups.
    
  